Stockreport

EXCLUSIVE: Oragenics Completes Spray Dry Drug Manufacturing, Intranasal Device Filling For Anticipated Mid-Stage Study For Patients With Brain Injury [Yahoo! Finance]

Oragenics Inc.  (OGEN) 
NASDAQ:AMEX Investor Relations: ir.oragenics.com
PDF Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications for infectious diseases and neurological conditions, incl [Read more]